OIG Efforts Expected to Recover $4.9 Billion in Improper Payments in FY 2014

Investigative and oversight efforts by the Department of Health and Human Services Office of Inspector General are expected to return $4.9 billion in improper payments to the government in fiscal year … [Read more...]

Leaders of Republican Doctors Caucus See No Action on SGR During Lame Duck

Efforts to find a long-term fix for Medicare‚Äôs Sustainable Growth Rate (SGR) formula for physician payment will have to wait until 2015, the co-chairman of the Republican-formed GOP Doctors Caucus … [Read more...]

Labs Express Concern About New MolDx Policy Requiring Registration of Molecular Test Panels

Groups representing clinical laboratories are coming out in opposition to a new alert issued by Palmetto GBA requiring labs that perform tests in Medicare regions JE or J11 to register molecular test … [Read more...]

Proposed Amendment to Conditions of Participation Recognizes Same-Sex Marriages

Hospital laboratory Medicare Conditions of Participation will be amended to protect the rights of patients in same-sex marriages. A proposed rule was released responding to the US Supreme Court … [Read more...]

CMS Releases New CLIA-Waived Tests, Billing Codes

CMS notified contractors of new CLIA-waived tests effective January 1, 2015. There are 25 newly waived complexity tests, the latest approved by the FDA. The tests, listed in the table below, all … [Read more...]

Enforcement Trends — Labs Continue to Be a Focus

Laboratories continue to draw attention from the Department of Justice (DOJ) and the Office of Inspector General (OIG) as 2014 came to a close. In December, the DOJ announced two guilty pleas and one … [Read more...]

EBOLA Continues to Warrant Attention From Labs

While public interest and mainstream media coverage of Ebola may appear to be waning, the outbreak has not ended and the latest CDC reports indicate the total cases exceeds 20,000 and is still rising. … [Read more...]

ACLA Issues White Paper Arguing Against FDA Regulation of LDT

As NIR reported in November, the American Clinical Laboratory Association (ACLA) has hired some renowned legal advisors to respond to the FDA's proposed regulation of laboratory developed tests (LDTs) … [Read more...]

NIR Current

NIR Current (redirect to current archive) … [Read more...]